Agilent Technologies Inc (NYSE: A) has reported earnings for its first fiscal quarter (ending January 31) of $1.12 versus $1.19 for the same period a year ago — a decline of -6%. For the latest […]
For its fourth fiscal quarter (ending December 31), Acadia Pharmaceuticals Inc (NASDAQ: ACAD) has reported a 207% increase in E.P.S. from $0.28 a year ago to $0.86 in the current quarter. E.P.S. were $1.37 for […]
AMERISAFE Inc (NASDAQ: AMSF) has reported E.P.S. of $0.69 for its fourth fiscal quarter (ending December 31) versus $1.00 for the same period a year ago — a decline of -31%. For the latest four […]
On 2/26/25, United Therapeutics Corp (NASDAQ: UTHR) stock suffered a major decline of -10.8%, closing at $318.89. Moreover, this decline was accompanied by exceptionally high trading volume at 435% of normal. The stock has declined […]
For its fourth fiscal quarter (ending January 31), The TJX Companies Inc (NYSE: TJX) has reported a 1% increase in E.P.S. from $1.22 a year ago to $1.23 in the current quarter. E.P.S. were $4.26 […]
For its fourth fiscal quarter (ending December 31), The Brink’s Co (NYSE: BCO) has reported a -700% decline in E.P.S. from $-0.14 a year ago to $0.84 in the current quarter. For the latest four […]
Synopsys Inc (NASDAQ: SNPS) has reported earnings for its first fiscal quarter (ending January 31) of $1.91 versus $2.87 for the same period a year ago — a decline of -33%. For the latest four […]
Spok Holdings Inc (NASDAQ: SPOK) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.18 versus $0.17 for the same period a year ago — an increase of 6%. For the latest […]
On 2/26/25, Globalstar Inc (NASDAQ: GSAT) stock enjoyed a major increase of 11.1%, closing at $21.74. Trading volume in this advance was normal. The stock has been exceptionally strong relative to the market over the […]
Dycom Industries Inc. (NYSE: DY) has reported E.P.S. of $1.12 for its fourth fiscal quarter (ending January 31) versus $0.80 for the same period a year ago — an increase of 40%. For the latest […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research